Discover
ALT
Altimmune, Inc.
3.15
2 x 2.44
2 x 3.89
bid
ask
+
0.11
3.62%
2 @ 07:36 AM
3.23 +0.08 (2.54%)
| Ytd | -12.74% | |
| 1y | -25.53% |
3.00
day range
3.40
2.56
52 week range
6.44
| Open | 3.02 | Prev Close | 3.04 | Low | 3.00 | High | 3.40 | Mkt Cap | 612.59M |
| Vol | 7.96M | Avg Vol | 4.21M | EPS | -0.92 | P/E | N/A | Forward P/E | -5.14 |
| Beta | 0.07 | Short Ratio | 5.81 | Inst. Own | 56.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-20 | Earning | 08-11 | 50-d Avg | 2.89 | 200-d Avg | 3.86 | 1yr Est | 22.86 |
| Income Statement | |||
| Operating Expenses | 24.24M | ||
| Research and Development Expense | 16.19M | ||
| Selling, General and Administrative Expense | 8.05M | ||
| Operating Income | -24.24M | ||
| Interest Expense | 1.07M | ||
| Net Income | -22.56M | ||
| Net Income Common Stock | -22.56M | ||
| Net Income Common Stock (USD) | -22.56M | ||
| Consolidated Income | -22.56M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -21.49M | ||
| Earning Before Interest & Taxes (USD) | -21.49M | ||
| Weighted Average Shares | 124.46M | ||
| Weighted Average Shares Diluted | 124.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 97.64M | ||
| Cash and Equivalents (USD) | 97.64M | ||
| Investments | 233.94M | ||
| Investments Current | 233.94M | ||
| Trade and Non-Trade Receivables | 1.67M | ||
| Current Assets | 334.68M | ||
| Property, Plant & Equipment Net | 208.00K | ||
| Total Assets | 335.63M | ||
| Total Debt | 34.51M | ||
| Current Liabilities | 11.32M | ||
| Debt Non-Current | 34.51M | ||
| Total Liabilities | 51.64M | ||
| Accumulated Retained Earnings (Deficit) | -672.05M | ||
| Accumulated Other Comprehensive Income | -5.22M | ||
| Shareholders Equity | 283.99M | ||
| Shareholders Equity (USD) | 283.99M | ||
| Assets Non-Current | 954.00K | ||
| Total Debt (USD) | 34.51M | ||
| Liabilities Non-Current | 40.32M | ||
| Trade and Non-Trade Payables | 1.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.00K | ||
| Net Cash Flow from Financing | 78.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 53.84M | ||
| Capital Expenditure | -21.00K | ||
| Issuance (Purchase) of Equity Shares | 79.26M | ||
| Net Cash Flow from Investing | -3.69M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.67M | ||
| Net Cash Flow from Operations | -20.94M | ||
| Share Based Compensation | 3.38M | ||